These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 23836736)
1. Increasing Medicare part D enrollment in medication therapy management could improve health and lower costs. Stuart B; Loh FE; Roberto P; Miller LM Health Aff (Millwood); 2013 Jul; 32(7):1212-20. PubMed ID: 23836736 [TBL] [Abstract][Full Text] [Related]
2. Impact of cost sharing on prescription drugs used by Medicare beneficiaries. Goedken AM; Urmie JM; Farris KB; Doucette WR Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109 [TBL] [Abstract][Full Text] [Related]
3. Regions with higher Medicare Part D spending show better drug adherence, but not lower medicare costs for two diseases. Stuart B; Shoemaker JS; Dai M; Davidoff AJ Health Aff (Millwood); 2013 Jan; 32(1):120-6. PubMed ID: 23297279 [TBL] [Abstract][Full Text] [Related]
4. Should eligibility for medication therapy management be based on drug adherence? Stuart B; Loh E; Miller L; Roberto P J Manag Care Pharm; 2014 Jan; 20(1):66-75. PubMed ID: 24511767 [TBL] [Abstract][Full Text] [Related]
5. Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population. Simoni-Wastila L; Wei YJ; Qian J; Zuckerman IH; Stuart B; Shaffer T; Dalal AA; Bryant-Comstock L Am J Geriatr Pharmacother; 2012 Jun; 10(3):201-10. PubMed ID: 22521808 [TBL] [Abstract][Full Text] [Related]
6. Impact of prescription coverage on hospital and physician costs: a case study of medicare beneficiaries with chronic obstructive pulmonary disease. Stuart B; Doshi JA; Briesacher B; Wrobel MV; Baysac F Clin Ther; 2004 Oct; 26(10):1688-99. PubMed ID: 15598486 [TBL] [Abstract][Full Text] [Related]
7. The economic impact of Medicare Part D on congestive heart failure. Dall TM; Blanchard TD; Gallo PD; Semilla AP Am J Manag Care; 2013 May; 19(6 Suppl):s97-100. PubMed ID: 23725537 [TBL] [Abstract][Full Text] [Related]
8. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25. Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112 [TBL] [Abstract][Full Text] [Related]
9. First-year Medicare Part D prescription drug benefits: medication access and continuity among dual eligible psychiatric patients. West JC; Wilk JE; Rae DS; Muszynski IL; Rubio-Stipec M; Alter CL; Sanders KE; Crystal S; Regier DA J Clin Psychiatry; 2010 Apr; 71(4):400-10. PubMed ID: 19925748 [TBL] [Abstract][Full Text] [Related]
10. Medication use and adherence among elderly Medicare beneficiaries with diabetes enrolled in Part D and retiree health plans. Stuart B; Simoni-Wastila L; Yin X; Davidoff A; Zuckerman IH; Doshi J Med Care; 2011 May; 49(5):511-5. PubMed ID: 21422956 [TBL] [Abstract][Full Text] [Related]
11. Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs. Esposito D; Bagchi AD; Verdier JM; Bencio DS; Kim MS Am J Manag Care; 2009 Jul; 15(7):437-45. PubMed ID: 19589011 [TBL] [Abstract][Full Text] [Related]
12. Does good medication adherence really save payers money? Stuart BC; Dai M; Xu J; Loh FH; S Dougherty J Med Care; 2015 Jun; 53(6):517-23. PubMed ID: 25961659 [TBL] [Abstract][Full Text] [Related]
13. Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis. Conwell LJ; Esposito D; Garavaglia S; Meadows ES; Colby M; Herrera V; Goldfarb S; Ball D; Marciniak M Am J Geriatr Pharmacother; 2011 Aug; 9(4):241-9. PubMed ID: 21616722 [TBL] [Abstract][Full Text] [Related]
14. Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase. Park H; Rascati KL; Lawson KA; Barner JC; Richards KM; Malone DC J Manag Care Spec Pharm; 2014 Aug; 20(8):862-76. PubMed ID: 25062080 [TBL] [Abstract][Full Text] [Related]
15. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans. Patel UD; Davis MM J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016 [TBL] [Abstract][Full Text] [Related]
16. Adverse selection in the Medicare prescription drug program. Riley GF; Levy JM; Montgomery MA Health Aff (Millwood); 2009; 28(6):1826-37. PubMed ID: 19887424 [TBL] [Abstract][Full Text] [Related]
17. Mitigation of medication mishaps via medication therapy management. Pindolia VK; Stebelsky L; Romain TM; Luoma L; Nowak SN; Gillanders F Ann Pharmacother; 2009 Apr; 43(4):611-20. PubMed ID: 19336646 [TBL] [Abstract][Full Text] [Related]
18. Antiparkinson drug adherence and its association with health care utilization and economic outcomes in a Medicare Part D population. Wei YJ; Palumbo FB; Simoni-Wastila L; Shulman LM; Stuart B; Beardsley R; Brown CH Value Health; 2014 Mar; 17(2):196-204. PubMed ID: 24636377 [TBL] [Abstract][Full Text] [Related]
19. Utilization and costs of cardiovascular disease medications in dialysis patients in Medicare Part D. Frankenfield DL; Weinhandl ED; Powers CA; Howell BL; Herzog CA; St Peter WL Am J Kidney Dis; 2012 May; 59(5):670-81. PubMed ID: 22206743 [TBL] [Abstract][Full Text] [Related]
20. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities. Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]